RAAS inhibitors do not increase the risk of COVID-19

被引：0
|
作者：
Irene Fernández-Ruiz
机构：
[1] Nature Reviews Cardiology,
来源：
Nature Reviews Cardiology | 2020年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in-hospital death among patients with COVID-19.
引用
收藏
页码：383 / 383
相关论文
共 50 条
  • [41] COVID-19 vaccines do not increase GP visits for menstrual disorders
    [J]. Reactions Weekly, 2024, 2003 (1) : 4 - 4
  • [42] COVID-19 Infections May Increase the Risk of SLE Flares
    Khalili, Leila
    Gartshteyn, Yevgeniya
    Schmidt, Nancyanne
    Kapoor, Teja
    Geraldino-Pardilla, Laura
    Askanase, Anca
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [43] COVID-19: PPIs increase the Risk of severe clinical Outcomes
    Lichert, Frank
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (04): : 308 - 308
  • [44] Psychosis and substance abuse increase the COVID-19 mortality risk
    Catalan, Ana
    Aymerich, Claudia
    Bilbao, Amaia
    Pedruzo, Borja
    Perez, Jose Luis
    Aranguren, Nerea
    de Pablo, Gonzalo Salazar
    Hedges, Emily
    Gil, Patxi
    Segarra, Rafael
    Gonzalez-Pinto, Ana
    Fernandez-Rivas, Aranzazu
    Inchausti, Lucia
    McGuire, Philip
    Fusar-Poli, Paolo
    Gonzalez-Torres, Miguel Angel
    [J]. PSYCHOLOGICAL MEDICINE, 2023, 53 (09) : 4236 - 4244
  • [45] COVID-19 vaccination does not increase risk of preterm labour
    [J]. Reactions Weekly, 2023, 1974 (1) : 10 - 10
  • [46] Multiple sclerosis immunotherapies increase risk of COVID-19 mortality
    [J]. Reactions Weekly, 2022, 1929 (1) : 10 - 10
  • [47] Confinement for COVID-19 could increase the risk of frailty in elderly
    Abraham Del Val-Gomez, R.
    [J]. REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2021, 14 : 105 - 106
  • [48] COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
    Sen, Selcuk
    Uresin, Ali Yagiz
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2020, 48 (07): : 631 - 634
  • [49] COVID-19 and the RAAS-a potential role for angiotensin II?
    Busse, Laurence W.
    Chow, Jonathan H.
    McCurdy, Michael T.
    Khanna, Ashish K.
    [J]. CRITICAL CARE, 2020, 24 (01)
  • [50] RAAS, ACE2 and COVID-19; a mechanistic review
    Elshafei, Ahmed
    Khidr, Emad Gamil
    El-Husseiny, Ahmed A.
    Gomaa, Maher H.
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (11) : 6465 - 6470
12345